金東烈 - Kim & Chang IP | 金・張法律事務所

紹介

Dr. Daniel Kim is a senior foreign attorney in the firm's Intellectual Property Practice focusing on all aspects of IP law.

Daniel’s practice covers all aspects of IP law, with a focus on patent prosecution and litigations in various technical areas including pharmaceuticals, chemicals, biotechnology, mechanical devices, medical devices, electronic and IT equipment.

Daniel has represented multinational companies in the pharmaceutical, chemical, and other fields in numerous cases to strongly protect the clients’ business. He regularly provides advice on litigation strategies, infringement/non-infringement, validity/invalidity, and freedom-to-operate. Daniel also provides counseling to clients in a variety of IP and technology transactions.

Prior to joining Kim & Chang, Daniel practiced at a leading IP firm in Korea and global U.S. law firms, focusing on patent prosecution, enforcement, portfolio management, client counseling, client development and other IP related issues.

Dr. Kim has co-authored various publications, and has given lectures/seminars before the audience at universities, private and public companies, research institutions and professional organizations.

Daniel is admitted to practice in Washington DC and California and is registered to practice before the U.S. Patent and Trademark Office. He received a Ph.D. in biochemistry and molecular biology from Purdue University and B.S. in food biotechnology from Seoul National University.

経歴

Kim & Chang (2014-Present)

Koreana Patent Firm (2007-2014)

DLA Piper (2006-2007)

Perkins Coie LLP (2005-2006)

Quinn Emanuel Urquhart & Sullivan, LLP (2002-2005)

Kim & Chang (2001)

主な活動View All

著書/活動

Recent statistics on Patent Court decisions reflect more favorable stance towards patentees (Co-author, ILO, 2017)
Firm representative: MIP Global Awards (London, March 2016)
The America Invents Act: Implications on Korean patent practice, In-House Seminar, 2009
U.S. Patent Practice and Related Matters, Lions Club, 2008
U.S. Patent Practice and Related Matters (Patent Prosecution, Patent Litigation and Implications of KOREA-US FTA on Patent Practice), Korea Research Institute of Chemical Technology (KRICT), 2007
USPTO: Using a Sledgehammer to Kill an Ant? In-House Seminar, 2007
Securities Class Action Filings and Settlements Down in 2003, Quinn Emanuel Business Litigation Report
California Supreme Court Adopts New Rules to Govern Out-Of-State Attorneys "Practicing" in California, Quinn Emanuel Business Litigation Report
3-hydroxy-3-methylglutaryl-CoA Reductase. 2000. Rodwell VW, Kim D, et al. Methods Enzymol.
Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus. 2000. Wilding EI, Kim D, et al. J. Bacteriol. (Both Kim and Wilding contributed equally).
Dual coenzyme specificity of Archaeoglobus fulgidus HMG-CoA Reductase. 2000. Kim D, et al. Protein Sci.
Engineering of Sulfolobus solfataricus HMG-CoA reductase to a form whose activity is regulated by phosphorylation and dephosphorylation. 1999. Kim D, et al. Biochemisty.
Expression and characterization of the HMG-CoA reductase of the thermophilic archaeon Sulfolobus solfataricus. 1999. Kim D, et al. Protein Expr. Purif.